Urgent Product Correction Notice FSCA This is to inform you of an Urgent Product Correction Notice involving:

Similar documents
PLEASE DELIVER UPON RECEIPT to LAB DIRECTOR or LAB MANAGER

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland

Use of monthly collected milk yields for the early detection of vector-borne emerging diseases.

Quality assurance of antimicrobial susceptibility testing

Chickens and Eggs. November Egg Production Up Slightly

ESCMID Online Lecture Library. by author

Chickens and Eggs. May Egg Production Down 5 Percent

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Chickens and Eggs. August Egg Production Up 3 Percent

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Chickens and Eggs. January Egg Production Up 9 Percent

Promoting Appropriate Antimicrobial Prescribing in Secondary Care

Chickens and Eggs. Special Note

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

Chickens and Eggs. December Egg Production Down 8 Percent

range of RA s accessible during the night.

range of RA s accessible during the night.

FREEDOM OF INFORMATION ACT

Class I Recall CLASS I RECALL

Antimicrobial Susceptibility Testing: Advanced Course

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Intrinsic, implied and default resistance

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Ready to Launch: Antimicrobial Stewardship for All!

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

DETECTION OF INHIBITORY SUBSTANCES IN MILK

MICRONAUT. diagnostics with passion. Use the reference method and fill the gap of your fully automated system

Board Meeting Agenda Item: 7.2 Paper No: Purpose: For Information. Healthcare Associated Infection Report

Chickens and Eggs. November Egg Production Up 3 Percent

Freedom of Information

Doxycycline for strep pneumonia

Can we trust the Xpert?

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

B. PACKAGE LEAFLET 1

Beef Calving Statistics (01/07/ /06/2016)

Introduction. Antimicrobial Usage ESPAUR 2014 Previous data validation Quality Premiums Draft tool CDDFT Experience.

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

Monthly Economic Review November 2017

Chickens and Eggs. February Egg Production Up Slightly

Chickens and Eggs. Special Note

Antibiotic usage in the British sheep industry. Dr Peers Davies

Antibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Chickens and Eggs. June Egg Production Down Slightly

Understanding the Hospital Antibiogram

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

The Danish risk management strategy for veterinary antimicrobial usage

Dredging Impacts on Sea Turtles in the Southeastern USA Background Southeastern USA Sea Turtles Endangered Species Act Effects of Dredging on Sea Turt

APPENDIX III - DOUBLE DISK TEST FOR ESBL

4-H LIVESTOCK RECORD BOOK

Nova Journal of Medical and Biological Sciences Page: 1

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Unasyn alternative if penicillin allergic

Animal Care, Control and Adoption

European Committee on Antimicrobial Susceptibility Testing

ESCMID Online Lecture Library. by author

EARS Net Report, Quarter

Background and Plan of Analysis

European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004

Animal Care, Control and Adoption

EUCAST recommended strains for internal quality control

UNDERSTANDING THE ANTIBIOGRAM

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Surveillance for Antimicrobial Resistance and Preparation of an Enhanced Antibiogram at the Local Level. janet hindler

A Case Study of the Effectiveness of TNR on a Feral Cat Colony

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Animal Care, Control and Adoption

Antimicrobial Stewardship Strategy: Antibiograms

CO-ACTION. Prof.dr. J.W. Mouton. Note : some technical and all results slides were removed. JPIAMR JWM Paris JWM Paris 2017

Models for stewardship in Hospital - UK Models Philip Howard Consultant Antimicrobial Pharmacist

Service Delivery and Safety Department World Health Organization, Headquarters

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship July December 2017

MOON PHASES FOR 2019, at Kitt Peak Times and dates are given in local time, zone = 7 hr West. They are generally better than +- 2 minutes.

MOON PHASES FOR 2018, at Kitt Peak Times and dates are given in local time, zone = 7 hr West. They are generally better than +- 2 minutes.

Jasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4

2016 Antibiotic Susceptibility Report

ANNEXES. to the Proposal. for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

An audit of the quality of antimicrobial prescribing

Benchmarking Antimicrobial Use

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Mechanism of antibiotic resistance

Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Active Constituent: Each tablet contains 500 mg cephalexin (as monohydrate) Contents: 12 [100, 300] Tablets

ANTIMICROBIAL STEWARDSHIP IN SCOTLAND. Key achievements of the Scottish Antimicrobial Prescribing Group

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

Listed Status Club (Obedience) APPLICATION FORM

Prescribing Quality Scheme 2017/18

GULF COAST AGRICULTURE & NATURAL RESOURCE YOUTH ORGANIZATION GCA & NRYO SPRING 2018 SHOW RECORD BOOK

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

Active Constituent: Each tablet contains 1000 mg cephalexin (as monohydrate) Contents: 8 [100, 300] Tablets

Can levaquin treat group b strep

Situation update of dengue in the SEA Region, 2010

Transcription:

20 April 2017 Urgent Product Correction Notice FSCA 3445 Dear This is to inform you of an Urgent Product Correction Notice involving: VITEK 2 Identification / Antimicrobial Susceptibility Test Cards referenced in Appendix A Our records indicate your laboratory received one or more of the affected products referenced in Appendix A. This letter is intended for all VITEK 2 Identification (ID) / Antimicrobial Susceptibility Testing (AST) users. This notice has been initiated due to potential for compromised test card pouch integrity which could: yield false resistance for antibiotics on the AST panel cause a false negative ESBL test result in a false positive urea (URE) reaction on ID cards Description of Issue: A potential issue was identified related to the white pouch which contains VITEK 2 test cards for the product lots specified in Appendix A. biomérieux has determined that the integrity of some of the VITEK 2 test card pouches may be compromised. Based on our investigation, a compromised test card pouch can impact card reagents due to the entry of moisture. The white pouch is composed of five (5) layers of material, four (4) of which are clear. All five layers must be compromised for a pouch to potentially allow moisture to enter the pouch. Upon visual inspection of the pouch, you may notice a small puncture or tear in the packaging at the "stitch seal" (see Figure A immediately below). Per product labeling, do not use the card if the pouch (the white protective package cover) is damaged. Based on internal testing, approximately 20% of card pouches exhibited a visual defect; the majority of card pouches with this visual defect maintained pouch integrity, i.e. at least one of the five material layers remained intact. However, 1 in 200 (0.5%) card pouches that passed careful visual inspection failed further integrity tests, indicating the potential for entry of moisture. biomérieux UK Ltd Grafton Way, Basingstoke, Hampshire, RG22 6HY Tel.: +44 (0)1256 461881 - Fax: +44 (0)1256 816863 - www.biomerieux.co.uk Registered Office: Grafton Way, Basingstoke, Hampshire, RG22 6HY Registered in England No. 1061914

Figure A - Example of Pouch Defect The root cause of this issue has been identified and corrective measures have been taken to ensure issues of this type do not affect future Manufacturing lots. Impact to customer/patient: biomérieux studies have demonstrated that a test card pouch defect can allow entry of moisture which can impact the test card reagents. Moisture sensitivity can lead to antibiotic degradation (loss of potency). The anticipated consequence would be elevated MIC results of some antimicrobials (leading to false-resistant results). The antimicrobial class most affected by moisture is the beta-lactam class. This includes penicillins, cephalosporins, and carbapenems. The most moisture-sensitive of the beta-lactams is imipenem. Therefore, it is the best indicator of a pouch defect. Two other moisture-sensitive antimicrobials are erythromycin and nitrofurantoin. One exception to the expected elevation in MICs (or false resistance) that can occur due to the pouch defect is the ESBL (Extended-Spectrum β-lactamase) test, which utilizes clavulanic acid in combination with three cephalosporins. Clavulanic acid is also moisture sensitive, and if degraded, the ESBL test could be falsely negative. The Advanced Expert System will determine presence of an ESBL phenotype based on results of all beta lactams, including the ESBL test. Therefore, the impact of a false negative ESBL test should be minimal.

For VITEK 2 Identification cards, URE may be sensitive to moisture and a false positive reaction may occur. However, there is low risk of impact to identification result as the identification (ID) algorithm generally allows two atypical reactions and will still provide a correct identification with a high degree of confidence. The knowledge bases are designed to account for both typical and atypical strains so an aberrant reaction should have low impact on identification results. Required Actions: - It is not necessary to discard all cards from an impacted lot. - We are recommending a careful visual examination of each test card pouch in the affected lots prior to use. 1. Check the lot numbers in your inventory against the lot numbers listed in Appendix A. 2. For impacted lots, visually inspect the test card pouches on both sides for the defect. a. If the defect is observed, destroy the associated test card(s) and contact our Technical Service Department on 0044 (0) 1256 480711 or email uktechnical@biomerieux.com for credit. b. If the defect is not observed, continue testing as per normal procedure, but increase monitoring for potential testing errors, as visual inspection may not identify all affected ID/AST cards. Repeat testing if you observe results potentially indicative of a pouch defect such as: i. A resistant imipenem result, particularly if unexpected and/or inconsistent with other results ii. A resistant or intermediate nitrofurantoin result which is unusual or inconsistent with other results iii. A resistant oxacillin or erythromycin result which is unusual or inconsistent with other results iv. Any quality control test result with these agents that is outside of the expected range 3. If imipenem is not tested, review other beta-lactams such as the penicillins, other carbapenems and/or cephalosporins for inconsistent resistance or unusual results, which may also indicate a potential pouch defect. 4. If concerns exist after repeat testing, alternative methods of establishing drug susceptibility should be used. If an unrelated performance issue is suspected, please follow your normal complaint escalation process.

Other Actions Related To This Notice: Please confirm this letter has been distributed and reviewed by all appropriate personnel within your organisation. Please store this letter with your biomérieux VITEK 2 documentation. Complete the attached Acknowledgement Form and return it for the attention of UKVIGILANCE to fax number 0044 (0) 1256 816863 or scan and email to UKVIGILANCE@biomerieux.com It is a requirement of the Competent Authority that this acknowledgement form be completed and returned even if you do not have the affected batches. biomérieux is committed to providing our customers with the highest quality products, and we apologise for any inconvenience this has caused your institution. If you have any questions or concerns, please contact our Technical Service Department on 0044 (0) 1256 480711 or email uktechnical@biomerieux.com Thank you for your continued use of biomérieux products. Yours sincerely UK VIGILANCE Department

Attachment A: Acknowledgement Form. URGENT PRODUCT CORRECTION NOTICE FSCA - 3445 VITEK 2 - Card Pouch Integrity It is a requirement of the Competent Authority that this form be completed and returned Please complete and return the acknowledgement form for the attention of UKVIGILANCE to fax number 0044 (0) 1256 816863 or scan and email to UKVIGILANCE@biomerieux.com Product Information: Catalog Number Multiple Description See Appendix A Questions: 1. Did you read the enclosed Urgent Product Correction Notice regarding VITEK 2 card pouch integrity? 2.Have you followed the instructions and implemented the actions as indicated in this Urgent Product Correction Notice? If no, please indicate the reason in the Comments section below. 3. Have you received reports of illness or injury related to the VITEK 2 card pouch defect? Comments: Yes No Signature: Date:

APPENDIX A 21341 - VITEK 2 GN ID Batch Expiry 241398120 7-Nov-2017 241398720 13-Nov-2017 2410037103 2-Jan-2018 2410071103 5-Feb-2018 2410072103 6-Feb-2018 2410091203 25-Feb-2018 21342 - VITEK 2 GP ID 2420157103 2-May-2018 2420185103 30-May-2018 2420200103 14-Jun-2018 2420253203 6-Aug-2018 21343 - VITEK 2 YST ID 2430199103 13-Jun-2018 21346 - VITEK 2 NH ID 2450162203 7-May-2018 2450204203 18-Jun-2018 2450221203 5-Jul-2018 21347 - VITEK 2 ANC ID 2440168103 13-May-2018 2440202103 16-Jun-2018 22335 - VITEK 2 AST P607 4870131203 6-Apr-2018 410028 - VITEK 2 AST ST01 5400122223 28-Mar-2018 5400136203 11-Apr-2018 5400136223 11-Apr-2018 5400136243 11-Apr-2018 5400192203 6-Jun-2018 5400192243 6-Jun-2018 5400199203 13-Jun-2018 5400216203 30-Jun-2018 5400221203 5-Jul-2018 5400238223 22-Jul-2018 5400238243 22-Jul-2018 5400269203 22-Aug-2018 Cont

APPENDIX A 412608 - VITEK 2 AST GN65 5850166103 11-May-2018 5850217403 1-Jul-2018 5850248103 1-Aug-2018 413410 - VITEK 2 AST GN84 6740247103 31-Jul-2018 413722 - VITEK 2 AST N253 6530208203 22-Jun-2018 413723 - VITEK 2 AST N243 6540146203 21-Apr-2018 6540252103 5-Aug-2018 6540290203 12-Sep-2018 414967 - VITEK 2 AST YS07 2870143203 18-Apr-2018 2870209403 23-Jun-2018 2870235203 19-Jul-2018 2870248403 1-Aug-2018 415671 - VITEK 2 AST P634 7340290103 12-Sep-2018 415672 - VITEK 2 AST N297 7170138203 13-Apr-2018 7170145203 20-Apr-2018 416911 - VITEK 2 AST P635 7350166103 11-May-2018 7350291103 13-Sep-2018 418424 - VITEK 2 AST GP76 2760186403 31-May-2018 2760241203 25-Jul-2018 420739 - VITEK 2 AST YS08 2880150203 25-Apr-2018 421037 - VITEK 2 AST N350 7900118203 24-Mar-2018 7900139203 14-Apr-2018 7900259103 12-Aug-2018 421040 - VITEK 2 AST ST03 5420269203 22-Aug-2018

APPENDIX A 421257 - VITEK 2 AST N351 791383620 16-Mar-2018 7910163203 8-May-2018 7910246203 30-Jul-2018 421258 - VITEK 2 AST N352 7920118203 24-Mar-2018 7920164103 9-May-2018 7920272103 25-Aug-2018